Abstract
OBJECTIVE--To assess the prevalence of symptoms and signs of acute mountain sickness of the Swiss Alps. DESIGN--A study using an interview and clinical examination in a representative population of mountaineers. Positive symptoms and signs were assigned scores to quantify the severity of acute mountain sickness. SETTING--Four huts in the Swiss Alps at 2850 m, 3050 m, 3650 m, and 4559 m. SUBJECTS--466 Climbers, mostly recreational: 47 at 2850 m, 128 at 3050 m, 82 at 3650, and 209 at 4559 m. RESULTS--In all, 117 of the subjects were entirely free of symptoms and clinical signs of acute mountain sickness; 191 had one or two symptoms and signs; and 158 had more than two. Those with more than two symptoms and signs were defined as suffering from acute mountain sickness. At 4559 m 11 climbers presented with high altitude pulmonary oedema or cerebral oedema, or both. Men and women were equally affected. The prevalence of acute mountain sickness correlated with altitude: it was 9% at 2850 m, 13% at 3050 m, 34% at 3650 m, and 53% at 4559 m. The most frequent symptoms and signs were insomnia, headache, peripheral oedema, and scanty pulmonary rales. Severe headache, vomiting, dizziness, tachypnoea, and pronounced pulmonary rales were associated with other symptoms and signs and therefore characteristic of acute mountain sickness. CONCLUSION--Acute mountain sickness is not an uncommon disease at moderately high altitude--that is, above 2800 m. Severe headache, vomiting, dizziness, tachypnoea, and pronounced pulmonary rales indicate severe acute mountain sickness, and subjects who suffer these should immediately descend to lower altitudes.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bärtsch P., Waber U., Haeberli A., Maggiorini M., Kriemler S., Oelz O., Straub W. P. Enhanced fibrin formation in high-altitude pulmonary edema. J Appl Physiol (1985) 1987 Aug;63(2):752–757. doi: 10.1152/jappl.1987.63.2.752. [DOI] [PubMed] [Google Scholar]
- Ferrazzini G., Maggiorini M., Kriemler S., Bärtsch P., Oelz O. Successful treatment of acute mountain sickness with dexamethasone. Br Med J (Clin Res Ed) 1987 May 30;294(6584):1380–1382. doi: 10.1136/bmj.294.6584.1380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hackett P. H., Rennie D., Levine H. D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 1976 Nov 27;2(7996):1149–1155. doi: 10.1016/s0140-6736(76)91677-9. [DOI] [PubMed] [Google Scholar]
- Hackett P. H., Rennie D. Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. Am J Med. 1979 Aug;67(2):214–218. doi: 10.1016/0002-9343(79)90393-0. [DOI] [PubMed] [Google Scholar]
- Hirata K., Masuyama S., Saito A. Obesity as risk factor for acute mountain sickness. Lancet. 1989 Oct 28;2(8670):1040–1041. doi: 10.1016/s0140-6736(89)91051-9. [DOI] [PubMed] [Google Scholar]
- Hochstrasser J., Nanzer A., Oelz O. Das Höhenödem in den Schweizer Alpen. Beobachtungen über Inzidenz, Klinik und Verlauf bei 50 Patienten der Jahre 1980-1984. Schweiz Med Wochenschr. 1986 Jun 28;116(26):866–873. [PubMed] [Google Scholar]
- Larson E. B., Roach R. C., Schoene R. B., Hornbein T. F. Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. JAMA. 1982 Jul 16;248(3):328–332. [PubMed] [Google Scholar]
- Montgomery A. B., Mills J., Luce J. M. Incidence of acute mountain sickness at intermediate altitude. JAMA. 1989 Feb 3;261(5):732–734. [PubMed] [Google Scholar]